Ledger.Open graph →
SEC Form D · filed May 6, 2009

Tokai Pharmaceuticals Inc

Offering
$22.0M
Sold
$10.0M
Exemption
—
Industry
Biotechnology
Location
Cambridge, MA
Type
—

People & firms on this filing (11)

Reinhard J. Ambros · Cambridge, MADirectorCampbell Murray · Cambridge, MADirectorJoseph A. Yanchik, Iii · Cambridge, MADirectorSeth L. Harrison · Cambridge, MAExec · DirectorDavid A. Kessler · Cambridge, MADirectorPaul Gaynor · Newton, MAExec · DirectorLyle L. Roggow · Duncan, OKDirectorJimmy C. Cooper · Duncan, OKDirectorLarry G. Badgley · Dallas, TXDirectorGene C. Howard · Dallas, TXDirectorScott Chappel · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗